JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) is produced by a number of different cell types (including activated T cells, B cells, macrophages, mast cells, endothelial cells and fibroblasts) in response to cytokine, immune and inflammatory stimuli. GM-CSF is a growth factor for granulocyte-macrophage, erythroid, megakaryocyte and eosinophil progenitors. On mature hematopoietic cells, GM-CSF activates the effector functions of granulocytes, monocytes and eosinophils. GM-CSF is species specific and human GM-CSF has no biological effects on mouse cells.
This product is produced from E. coli and is manufactured in a facility that does not use or process beta-lactam containing materials. No animal- or human-derived materials were used during manufacturing or as ingredients. This product is manufactured, tested, and released in an ISO 9001:2015 certified facility and follows cGMP practices. USP chapter <1043> for ancillary materials considered in the manufacture of this product.
> 98% by reducing and non-reducing SDS-PAGE
ED50 < 0.2 ng/ml, determined by dose-dependent proliferation of human TF-1 cells.
~1.6 x 104 IU/µg, which is calibrated against the recombinant Human GM-CSF WHO International Standard (NIBSC code 88/646).
< 0.02 EU/µg using USP <85> / EP 2.6.14
Lyophilized vial is shipped at ambient temperature. Immediately upon receipt, store unopened vial at -20°C (manual defrost freezer) or -80°C for up to 36 months.
For ex vivo use only. Not for injection or diagnostic procedures. The safety and efficacy of this product in diagnostic or other clinical uses has not been established.